The customer stated that they received an erroneous result for one patient sample tested for (b)(6) on a cobas 8000 e 801 module (e801).The erroneous result was not reported outside of the laboratory.The sample was tested on the e801 analyzer, resulting as 0.1 coi ((b)(6)).The sample was also tested using the mediease tpla method on a cobas 6000 c (501) module, resulting as 49.0 t.U.((b)(6)).The sample also resulted with values of 40.0 t.U.And 29.0 t.U.When tested with the mediease tpsa method.The sample had an rpr value of 0.3.No units of measure were provided for the rpr value.No adverse events were alleged to have occurred with the patient.The serial number of the e801 analyzer was asked for, but not provided.
|
The mediase tpla test has been clarified as the mediace tpla assay.The affected sample was tested at another site (sekisui) using different test methods, including mediace tpla, espline tp by fujirebio, "other company rpr reagent", and recomline treponema igg/igm western blots.Refer to the attachment for all additional sample results.Data was provided for a second patient sample, but this sample had no issues.The negative syph result measured by the customer was confirmed negative by the recomline treponema igg/igm western blots.The non-treponemal testing (rpr) result was negative as well.In contrast, tpla testing is positive.The investigation was unable to find a definitive root cause.No further sample volume was available for additional investigation.(b)(6).
|